Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지

False Positive and False Negative FDG- PET Scans in Various Thoracic Diseases

  • Chang, Jung-Min (Department of Radiology, Seoul National University Hospital) ;
  • Lee, Hyun-Ju (Department of Radiology, Seoul National University Hospital) ;
  • Goo, Jin-Mo (Department of Radiology, Seoul National University Hospital) ;
  • Lee, Ho-Young (Department of Nuclear Medicine, Seoul National University Hospital) ;
  • Lee, Jong-Jin (Department of Nuclear Medicine, Seoul National University Hospital) ;
  • Chung, June-Key (Department of Nuclear Medicine, Seoul National University Hospital) ;
  • Im, Jung-Gi (Department of Radiology, Seoul National University Hospital)
  • Published : 2006.03.31
⟨ Previous Next ⟩

Abstract

Fluorodeoxyglucose (FDG)-positron emission tomography (PET) is being used more and more to differentiate benign from malignant focal lesions and it has been shown to be more efficacious than conventional chest computed tomography (CT). However, FOG is not a cancer-specific agent, and false positive findings in benign diseases have been reported. Infectious diseases (mycobacterial, fungal, bacterial infection), sarcoidosis, radiation pneumonitis and post-operative surgical conditions have shown intense uptake on PET scan. On the other hand, tumors with low glycolytic activity such as adenomas, bronchioloalveolar carcinomas, carcinoid tumors, low grade lymphomas and small sized tumors have revealed false negative findings on PET scan. Furthermore, in diseases located near the physiologic uptake sites (heart, bladder, kidney, and liver), FDG-PET should be complemented with other imaging modalities to confirm results and to minimize false negative findings. Familiarity with these false positive and negative findings will help radiologists interpret PET scans more accurately and also will help to determine the significance of the findings. In this review, we illustrate false positive and negative findings of PET scan in a variety of diseases.

Keywords

References

  1. Goo JM, Im JG, Do KH, Yeo JS, Seo JB, Kim HY, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 2000;216:117-121 https://doi.org/10.1148/radiology.216.1.r00jl19117
  2. Kostakoglu L, Agress H, Goldsmith SJ. Clinical role of FDG PET in evalutaion of cancer patients. RadioGraphics 2003;23:315-340 https://doi.org/10.1148/rg.232025705
  3. Trukington TG, Coleman RE. Clinical oncologic PET: An Introduction. Semin Roentgenol 2002;37:102-109 https://doi.org/10.1016/S0037-198X(02)80029-3
  4. Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (< 1 cm), intermediate (1 to 3 cm), and large (> 3 cm) lymph node lesions. Chest 2000;117: 773-778 https://doi.org/10.1378/chest.117.3.773
  5. Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, Bhargava P, et al. Positron emission tomography Imaging in nonmalignant thoracic disorders. Semin Nucl Med 2002;32: 293-321 https://doi.org/10.1053/snuc.2002.127291
  6. Amerein PC, Larson SM, Wagner HN Jr. An automated system for measurement of leukocyte metabolism. J Nucl Med 1975;15:352-355
  7. Crystal RG. Disorders of the immune system, connective tissue, and joints, sarcoidosis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principle of internal medicine, 15th ed. NewYork: McGraw-Hill, 2001;1969- 1970
  8. Bakheet SM, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 1998;28:352-358 https://doi.org/10.1016/S0001-2998(98)80038-X
  9. Brudin LH, Valind SO, Rhodes CG, Pantin CF, Sweatman M, Jones T, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994;21:297-305 https://doi.org/10.1007/BF00947964
  10. Bennett JE. Cryptococcosis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principle of internal medicine 15th ed. NewYork: McGraw-Hill, 2001;1174-1175
  11. Watanabe S, Nakamura Y, Kariatsumari K, Nagata T, Sakata R, Zinnouchi S, et al. Pulmonary paragonimiasis mimicking lung cancer on FDG-PET imaging. Anticancer Res 2003;23:3437- 3440
  12. Im JG, Kong Y, Shin YM, Yang SO, Song JG, Han MC, et al. Pulmonary paragonimiasis: clinical and experimental studies. RadioGraphics 1993;13:575-586 https://doi.org/10.1148/radiographics.13.3.8316665
  13. Lorenzen J, Buchert R, Bleckmann C, Munchow N, Bohuslavizki KH. A search for the focus in patients with fever of unknown origin: is positron-emission tomography with F-18- fluorodeoxyglucose helpful? Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1999;171:49-53 https://doi.org/10.1055/s-1999-9892
  14. Lin P, Chu J, Pocock N. Fluorine -18 FDG dual-head gamma camera coincidence imaging of radiation pneumonitis. Clin Nucl Med 2000;25:866-869 https://doi.org/10.1097/00003072-200011000-00002
  15. Speizer FE. Environmental lung diseases. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Principle of internal medicine, 15th ed. NewYork: McGraw-Hill, 2001;1470-1471
  16. Hara M, Iida A, Tohyama J, Miura N, Shiraki N, Itoh M, et al. FDG-PET findings in sclerosing hemangioma of the lung: a case report. Radiat Med 2001;19:215-218
  17. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-1980
  18. Kim B, Kim Y, Lee K, Yoon SB, Cheon EM, Kwon OJ, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 1998;170:935-939 https://doi.org/10.2214/ajr.170.4.9530038
  19. Berger KL, Nicholson SA, Dehdashti F, Siegel BA. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol 2000;174: 1005-1008 https://doi.org/10.2214/ajr.174.4.1741005
  20. Montravers F, Grahek D, Kerrou K, Younsi N, Doublet JD, Gattegno B, et al. Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera. J Nucl Med 2000;41:78-84
  21. Avril N, Rose CA, Schelling M, Dose J, Kuhn W, Bense S, et al. Breast imaging with positron emission tomography and fluorine- 18 fluorodeoxtglucose: use and limitations. J Clin Oncol 2000;18:3495-3502 https://doi.org/10.1200/JCO.2000.18.20.3495
  22. Ryu JS, Choi NC, Fischman AJ, Lynch TJ, Mathisen DJ. FDGPET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. Lung Cancer 2002;35:179-187 https://doi.org/10.1016/S0169-5002(01)00332-4
  23. Erasmus JJ, McAdams HP, Patz EF Jr, Coleman RE, Ahuja V, Goodman PC. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol 2004;182:559- 567 https://doi.org/10.2214/ajr.182.3.1820559